We therefore designed a case-control study to look into genetic risk profiles of CUA in the German calciphylaxis registry patients based on a target gene approach and included the CD73 (or NT5E) gene in the list, besides genes of the CKD-MBD complex and genes related to intrinsic calcification inhibitors. This evidence concerns the gene NT5E and chronic kidney disease.